Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Juvenile Myelomonocytic Leukemia

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

‹

Leukemia (1940)

Acute Myelogenous Leukemia (899)

Acute Lymphocytic Leukemia (388)

Chronic Lymphocytic Leukemia (292)

Chronic Myeloid Leukemia (255)

B Acute Lymphoblastic Leukemia (163)

T Acute Lymphoblastic Leukemia (38)

Childhood B Acute Lymphoblastic Leukemia (37)

Hairy Cell Leukemia (19)

Chronic Myelomonocytic Leukemia (18)

Prolymphocytic Leukemia (16)

Acute Promyelocytic Leukemia (12)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

Leukemia (1940)

Acute Myelogenous Leukemia (899)

Acute Lymphocytic Leukemia (388)

Chronic Lymphocytic Leukemia (292)

Chronic Myeloid Leukemia (255)

B Acute Lymphoblastic Leukemia (163)

T Acute Lymphoblastic Leukemia (38)

Childhood B Acute Lymphoblastic Leukemia (37)

Hairy Cell Leukemia (19)

Chronic Myelomonocytic Leukemia (18)

Prolymphocytic Leukemia (16)

Acute Promyelocytic Leukemia (12)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

›

No biomarker	Juvenile Myelomonocytic Leukemia	No biomarker	Juvenile Myelomonocytic Leukemia	azacitidine Sensitive: A1 - Approval azacitidine Sensitive : A1	azacitidine Sensitive: A1 - Approval azacitidine Sensitive : A1
KRAS mutation	Juvenile Myelomonocytic Leukemia	KRAS mutation	Juvenile Myelomonocytic Leukemia	decitabine Sensitive: C4 – Case Studies decitabine Sensitive : C4	decitabine Sensitive: C4 – Case Studies decitabine Sensitive : C4
ETV6-FLT3 fusion	Juvenile Myelomonocytic Leukemia	ETV6-FLT3 fusion	Juvenile Myelomonocytic Leukemia	gilteritinib Sensitive: C4 – Case Studies gilteritinib Sensitive : C4	gilteritinib Sensitive: C4 – Case Studies gilteritinib Sensitive : C4
SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia	SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia	trametinib Sensitive: D – Preclinical trametinib Sensitive : D	trametinib Sensitive: D – Preclinical trametinib Sensitive : D